Screening for DR!
RetCAD™ automatically analyses color fundus images and provides the user with a score and heat map that indicate referable disease symptoms.
I am incredibly honored and grateful to announce that I am the Ophthalmologica Lecturer 2024.
This prestigious award acknowledges the importance of clinical research focused on evidence-based retinology.
Looking forward to #EURETINA24@OUH_Eye@Rigshospitalet
Our CTO Rita Priori commenting on the 'art' of a succesful deployment of machine learning models to turn the data into business value in the article by @nyike : https://t.co/Ks2iVvpvZi
Continue my teaching activities in the Philippines. Tomorrow I will speak about AI in Ophthalmology in Davao, and the day after tomorrow in Manila. Everybody is welcome.
Sign up for free today and start using RETFound!
RETFound is the world's first retinal foundation model, created by a cross-institutional team led by @Moorfields and @ucl, and trained on 1.6 million retinal images.
Fancy joining me, with two of your friends, for a game at Royal Troon on September 10th?
Just follow me (if you don’t already) and then -
1. LIKE this tweet and
2. REPLY with your prediction of the winning score (to par) at The Open.
RT for 2 entries.
Good luck!!
🚨 OPEN GIVEAWAY 🚨
To celebrate this years Open held at Royal Troon we are giving away Official Open Merchandise
To enter simply 👇
Like this post 👍
Follow my account @McKenna_PGA
The winner will be announced after the final round on Sunday
Best of luck 🤞 🍀
Patient satisfaction with AI-based DR screening is high, one study stating it's over 99%.
AI integration boosted patient experience by removing barriers like travel and dilation, providing instant education, and high accuracy that led to proper eye care.
https://t.co/cthhrG1fZC
This abstract illustrates the robustness and sensitivity of automated BA analysis and its contribution to enhance the comprehensiveness of the @EMBARCnetwork Bronchiectasis registry.
https://t.co/R9CJEsagyl
Primary studies using #LungQ#AVX show that #AI could redefine diagnosis and treatment of pulmonary vascular diseases.
Read up on new frontiers in phenotyping blood vessels in the blog by Leticia Gallardo Estrella: https://t.co/LlKiZgiaEC
Our automated Bronchus-Artery analysis has been used to assess bronchus and artery dimensions and ratios throughout the airway tree in this study on PCD, showing the ability of automated BA analysis to successfully identify BA pairs on chest CT.
https://t.co/1HB52eKjH2
Stanford study: Patients screened for DR with AI are 3x more likely to follow up with an eye care specialist. https://t.co/jbSmSTygVl
Request a demo of the Optomed Aurora AEYE today and join the eye care revolution!
https://t.co/6Q9PuN706W
Our CMO Harm Tiddens talking about #AI-based assesment of #mucus in airway disease at the XI Bronchitis Symposium at @UMCG in Groningen.
#Bronchiectasis
Join us at the American Diabetes Association's 84th Scientific Sessions in Orlando, FL! On Sunday, 1:30-1:50, Dr. Cooper will reveal the first FDA-cleared handheld AI-equipped fundus camera for the detection of diabetic retinopathy. Visit Optomed at Booth 512!
Thank you to @stewartcdickson, Chair of the Assembly’s All Party Group on Diabetes, for making a statement to the Assembly on #DiabetesWeek on the importance of diabetes health checks.
Although intra-operative imaging such as Cone-Beam CT (#CBCT) is used to overcome CT-to-body-divergence, Thirona's AI can play a substantial role in facilitating a robust analysis of the images, providing valuable information during the procedure.
Positive impact is the major driving force behind our company.
We are passionate about continuously exploring new grounds for developing novel solutions for and together with our customers.